This study examines the relationship between regulatory B (Breg) and T (Treg) compartments, which play crucial roles in the maintenance of immune homeostasis in the context of HIV. Using flow cytometry, the phenotypes of different Breg and Treg subsets from HIVinfected and healthy individuals were analyzed, along with the suppressive capacity of Breg. 
Introduction HIV infection induces a general dysregulation of the immune system (IS), which can be defined as unrestrained or unregulated immune responses. In the case of the HIV, this implies a general loss of immune cell function and chronic inflammation, which lead to immune exhaustion, where almost all cells of the IS lose their functional ability. B and T cell exhaustion is characterized by an increase of the activated phenotype, a decrease of proliferative ability, and the loss of their effector capacity. These outcomes are related to uncontrolled viral persistence and disease progression [1, 2] . Recently, regulatory B and T cells (Breg and Treg, respectively) have been described to participate in the maintenance of immune homeostasis, of which one aim is to suppress the over-reaction in the case of inflammation, which leads to an appropriate immune response [3] [4] [5] .
Breg are immunosuppressive cells that support immunological tolerance, and several subsets of Breg have been defined such as CD19 + CD24 hi CD38 hi [6] , CD19 + CD24 hi CD27 + [7] , CD19 + CD5 + CD1d hi [8] , T-cell immunoglobulin and mucin domain 1 CD19 + (TIM-1 + B cells) [9] , programmed death-ligand 1 CD19 + (PD-L1 + B cells) [10] , CD19 + CD73 -CD25 + CD71 + [11] , CD19 + CD39 hi [12] or CD19 + CD23 + sIgM hi sIgD hi CD21/ CD35 hi marginal zone precursor B cells [13] . Currently, the IL-10 expression is the only clear marker defining a suppressive B-cell population in mice and humans, although more recently, Breg function has also been defined as independent of IL-10 [14, 15] . The mechanism of action of Breg in HIV infection is not yet well established, but the frequency of some Breg subsets is dysregulated in the chronic phase of HIV infection and loses its suppressive function over HIV-specific T cells [16, 17] .
The loss of the function of HIV-specific CD8 + T lymphocytes is also attributed to Treg in HIV infection [16, [18] [19] [20] [21] . Treg is a subset of CD4 + T cells that control hyperactivation of the IS due to their suppressive capacity [22] . Their role in HIV infection is still debated, and studies on Treg dysregulation and function in HIV + patients have shown dual impacts. Therefore, high levels of Treg in HIV + patients are related to reduced immune activation [23] . However, a high level of Treg is related to a high viremia associated with poor immune restoration [24] and persistence of the HIV reservoir [25] . The relation between Breg and Treg is not well established in HIV infection, but it might be assumed that they are implicated in the general imbalance of the IS since both compartments are dysregulated [20, 26] . We analyzed different Breg subsets and the Treg compartment to understand their interrelation in HIV infection better. We determined that frequencies of Breg and Treg were significantly higher in HIV + treatment-naïve individuals, but their absolute numbers were significantly decreased in the peripheral blood of these individuals. On the other hand, we observed that some Breg subsets are associated with the frequency of IL-10-producing B cells in healthy conditions. However, this correlation was lost in HIV 
Materials and methods

Patients
All individuals were recruited under a protocol that was approved by the Clinical Ethics Committees of the Ramón y Cajal Hospital and the Gregorio Marañón Hospital and according to the principles of the Declaration of Helsinki (Clinical Ethics Committees references: RyC-419-14 and HGUGM-04/2015, respectively). The data analysis was based on anonymized routine clinical data. Written informed consent was obtained from all the study participants. The research was conducted between December 2014 and December 2016. All samples were freshly processed on the day of the blood extraction within 1 h after sample collection. We studied three groups of individuals: i) HIV-infected treatment-naïve individuals (Naïve). This group comprised newly diagnosed HIV-1 + patients who did not receive antiretroviral treatment and presented a detectable viral load in plasma (VL >50 copies/mL); ii) treated-HIV-1 + individuals (Treated); HIV + patients who received antiretroviral treatment and presented an undetectable viral load (VL < 50 copies/ml in plasma), and iii) healthy individuals (Control); individuals who were not infected by HIV and were considered as a control group. A positive diagnostic of HIV-1 was obtained by enhanced ELISA assays that detected both HIV antibody and antigen (4th generation assay) which enables earlier detection of HIV seroconversion, followed by confirmation by Western Blot.
Direct labeling of whole blood and intracellular labeling
Whole blood was labeled, lysed, and analyzed by flow cytometry. The antibodies and fluorochromes used in this work are shown in the S1 and S2 Tables. The absolute numbers of immune subsets were determined using Flow-Count Fluorospheres and Flow-Count method (Beckman Coulter, Nyon, Switzerland). Peripheral blood mononuclear cells (PBMCs) were isolated with Lymphocyte Isolation Solution (Rafer SL, Zaragoza, Spain). To detect IL-10-producing Breg, 1x10 6 PBMCs were stimulated with CD40L (Alexis Biochemical; 200ng/ ml, Barcelona, Spain), LPS (Sigma-Aldrich; 1μg/ml, Darmstadt, Germany) and CpG-B oligodeoxynucleotide-2006 (CpG; Eurogentec SA; 10μg/ml, Seraing, Belgium) for two days. This mix of stimuli was described to induce the Breg phenotype in vitro [7] . Further, cells were activated with phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich; 10ng/ml) and ionomycin (Sigma-Aldrich; 0.25μg/mL) for 5 h at 37˚C in 5% CO 2 . GolgiStop (BD Biosciences, Madrid, Spain) was added after the first 1 h of PMA/ionomycin stimulation. The cells were then stained for surface markers, followed by intracellular staining (IL-10) using a Cytofix/Cytoperm kit (BD Biosciences, San Jose, CA, USA). To detect Treg, 1×10 6 freshly isolated PBMCs were stained for surface markers followed by intracellular staining using a Foxp3/Transcription Factor Staining Buffer Set (eBiosciences, Waltham, Massachusetts, USA). The cells were then analyzed by flow cytometry by using a Gallios cytometer (Beckman Coulter), and data were analyzed using Kaluza Analysis software (Beckman Coulter).
Definition of clinical markers and cellular phenotypes
The CD4 nadir and the CD4 nadir count are the lowest points to which the CD4 frequency and CD4 count dropped and were obtained from the patients' clinical records. The CD4/CD8 ratio reflects immune system health and was calculated using the frequencies of CD4 
Proliferation assay
B cells were isolated from PBMCs using anti-human CD19 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) with purity > 96%. They were then treated for two days with CpG-B/CD40L/LPS, which is a mixture that induces the Breg regulatory phenotype. Unstimulated B cells are B cells cultured with only the medium and were used as a negative control. After two days, stimulated and unstimulated B cells were washed with PBS (Biochrom, Cambridge, UK) before co-culture. Next, autologous CFSE-labeled CD19-depleted PBMCs (50,000 cells) (CFSE from Life technologies, Alcobendas, Spain) were co-cultured with stimulated or unstimulated-B cells (100,000 cells) and then stimulated with 50,000 anti-CD3/anti-CD28-coated magnetic beads (Dynabeads, Life technologies). After 72 h, the cells from the cocultures were harvested and labeled with anti-CD4 and anti-CD8 antibodies (Beckman Coulter). The viability was observed using 0. 
Statistical analysis
A non-parametric Kruskal-Wallis ANOVA test was performed to compare cell populations between healthy individuals (control) and HIV-1 + treatment-naïve (Naïve) or treated-HIV-1 + individuals (Treated), as well as to study the suppressive function of B cells. Mann-Whitney tests with Bonferroni correction for multiple testing were then used when the conditions presented significance (p<0.05 in the Kruskal Wallis test). The data are represented as the median ± interquartile range (IQR). The statistical correlation between variables was calculated using a Spearman rank correlation analysis. P values below 0.05 were considered statistically significant. All analyses were performed using SPSS 17.0 (IBM, Chicago, USA).
Results
Clinical composition
We evaluated 39 individuals who were divided into three groups. There were 13 HIV-infected treatment-naïve individuals with a detectable plasma viral load (VL>50 copies/mL; Naïve), 14 treated-HIV + individuals (Treated), and 12 healthy individuals (Control). The three groups were homogeneous according to age and sex (Table 1) .
HIV + treatment-naïve individuals were recruited at the time of diagnosis just before starting antiretroviral treatment. They showed a median of plasma VL of 6.31x10 5 copies/ml Table 1) . The frequency and absolute B cell numbers at sampling also decreased in naïve individuals in comparison to treated-HIV + individuals and healthy individuals ( Table 1) .
Dysregulation of Treg compartment in viremic HIV + patients
We investigated the presence of Treg (CD4
in HIV + patients (S1A Fig) and compared to the frequency, the absolute number of Treg cells was significantly decreased in HIV + treatment-naïve individuals (Fig 1A) , as expected. No differences were observed in frequency or counts of activated Treg between groups. However, the percentage and counts of the Treg TemRA were increased in treated-HIV + individuals (S1A Fig and Fig 1B) .
Interestingly, the increase of Treg (and activated Treg) frequencies in HIV + treatmentnaïve individuals correlated negatively with the CD4/CD8 ratio (Fig 1C) , perhaps in an attempt to reestablish the T-cell homeostasis lost during HIV infection (CD4 + T-cell depletion (Table 1) and CD8 + T-cell expansion (data not shown). Moreover, Treg cellular counts in HIV + individuals were also positively correlated with nadir count, which is related to the disease progression (Fig 1D) . Effective anti-HIV treatment enabled a reversion of the decrease in cell count of total Treg but did not allow the reversion of Treg TemRA levels ( Fig 1B) . Therefore, T-cell populations were undergoing profound changes that were not all reversed with the use of the treatment.
Dysregulation of Breg compartment in viremic HIV + patients
The Breg subsets exert a regulatory function that suppresses pathogenic T cells and helps in the maintenance of the Treg. We studied the presence of various Breg subsets (S2 (Fig 2C) . Furthermore, we also showed that the frequency of CD19 + TIM-1 + was increased in HIV + treatment-naïve individuals, but not the absolute counts (Fig 2D) . Thus, the Treg compartment was dysregulated by the presence of HIV, but also the Breg compartment. Breg subsets presented a general increase in frequencies and a general decrease in absolute counts in HIV + treatment-naïve individuals in comparison to treated-HIV + or healthy individuals.
IL-10-production in B cells and Breg subsets
The determination of Breg by cell surface markers must be performed with care since it has been demonstrated that HIV can directly or indirectly modify the expression of surface markers such as CD27 [20, [30] [31] [32] . IL-10 has an anti-inflammatory and suppressive effect on most + Breg subsets (Fig 3A) and in total stimulated or unstimulated B cells (Fig 3B) . The IL-10 detected in unstimulated B cells represents the basal level of IL-10-B-cell production.
In treated-HIV + individuals, we distinguished two groups of patients: those that expressed high frequency of intracellular IL-10 in B cells, and those that did not express intracellular IL-10 or only slightly expressed it (Fig 3A and 3B) . Hence, we analyzed their relationship with other markers, and a correlation was observed between the IL-10-producing unstimulated total B cells and CD4 nadir count in treated-HIV + individuals (Fig 3C) . Therefore, the basal ability of total B cells to produce IL-10 could possibly be related to disease progression since a low CD4 nadir count is associated with upcoming outcomes in the course of HIV disease [33, 34] . Moreover, in treated-HIV + individuals, we found a negative correlation between the frequency of the total stimulated IL-10-producing B cells and the years diagnosed or the years with undetectable VL (Fig 3D) . A correlation was also observed between years with undetectable VL and the frequency of CD4 + T cells expressing PD-1, an exhaustion marker that is related to the impairment of the CD4 + T cell population over time (Fig 3E, S1B Fig) . Moreover, the same marker was negatively correlated with the frequency of stimulated IL-10-producing B cells (Fig 3F) . Therefore, the loss of IL-10 production in stimulated B cells in treated-HIV + individuals was associated with CD4 + T-cell exhaustion during HIV infection in the absence of viral replication.
Loss of T-cell proliferation ability in HIV + patients
To determine whether Breg cells conserved their function, B cells isolated from PBMCs were stimulated with CD40L/LPS/CpG for two days. This mix of activators is known to activate the Breg subsets [7] . Unstimulated B cells from the same individuals were used as a control. After two days, unstimulated and stimulated B cells were co-cultured with autologous CFSElabeled PBMCs to observe the ability of the activated Breg to suppress the proliferation of the CFSE-PBMCs (Fig 4A) . The suppressive capacity of stimulated B cells (condition of Breg induction) over CD4 + and CD8 + T cell proliferation was observed and compared with the suppressive ability of unstimulated B cells (non-Breg induction). Unstimulated B cells did not show a suppressive function over PBMC proliferation, as expected (Fig 4A and 4B) . In contrast, stimulated B cells from healthy individuals (Control) showed the ability to limit PBMCs proliferation (Fig 4A) . On the other hand, the capacity of stimulated B cells to restrict the CFSE-CD4 + T-cell proliferation was lost in HIV + treatment-naïve individuals compared to treated-HIV + or healthy controls (Fig 4B) . The suppression of the CD8 + T-cell proliferation was decreased when co-cultured with stimulated B cells from HIV + treatment-naïve individuals, but the decrease was not significant in comparison to the suppression of the CD4 + T-cell proliferation (Fig 4B) . Furthermore, increased proliferation was observed in some HIV + treatment-naïve individuals instead of suppression (represented by a negative percentage of suppression in Fig 4B) . This suggests that B cells activated with Breg-associated stimuli either had utterly lost their suppressive Because of the heterogeneity of the suppressive ability over CD4 proliferation observed in HIV + treatment-naïve individuals (Fig 4B) , we analyzed the correlations that the suppression of CD4 proliferation have with the CD4/CD8 ratio and the Breg subsets phenotype. Interestingly, there was a positive correlation between the frequency of suppression of CD4 proliferation and the CD4/CD8 ratio in HIV + treatment-naïve individuals (Fig 4C) . Moreover, a positive correlation was observed between the frequency of suppression of CD4 + T cell proliferation and cell counts of CD24 hi CD27 + Breg subset (Fig 4D) 
Breg subsets might be functionally distinct
The IL-10 production is closely linked to Breg function. Since we observed changes in frequency and absolute numbers of several Breg subsets (Fig 2) , we analyzed whether there was a correlation between the frequency of Breg subsets and IL-10-producing B cells. (Table 2) . Thus, these four Breg subsets cannot be functionally related since they presented different correlations with the B-cell function such as the IL-10 production or with the frequency of Treg, which are two important markers in the regulation of the immune system during HIV infection.
Discussion
To our knowledge, this is the first time that the relationships between regulatory immune cell compartments where a general dysregulation of phenotype and function occur have been hi [16, 19, 35 ].
Regulatory cells imbalance in HIV infection
However, the major difference in our work is that we studied IL-10 intracellular expression in PBMCs stimulated with a mix of stimuli (CD40L, CpG and LPS) that induces a Breg phenotype. This contrasts with other works where the labeling was performed directly on freshly isolated PBMCs stimulated with PMA+ionomycin [18, 19, 35] . Another study on common variable immunodeficiency showed that Breg were defective in IL-10 expression and that the frequency of IL-10-producing CD24 hi CD38 hi or CD24 hi CD27 + B cells was decreased when the cell culture contained CpG [36] . Therefore, the induction of IL-10 production by Breg is highly dependent on the type of stimulation used. During HIV infection, the total B-cell compartment shows dysregulated counts and function via contact with the T lymphocytes or viral particles [20, 31, 37] . We previously demonstrated that HIV by itself is able to dysregulate B cells in vitro through a Breg-like phenotype [20] . Moreover, a low proportion of IL-10-producing B cells was observed in viremic controller individuals in comparison to viremic individuals [38] . Therefore, we hypothesized that the presence of viral replication could increase the IL-10-producing cells, although the mechanism is not yet known. In our work, we did not observe a change in the level of IL-10 production in of HIV infection could be related to the IL-10 production ability and CD4 + T-cell exhaustion.
Because it has been hypothesized that the Breg compartment might be dysregulated as a consequence of chronic inflammation in autoimmune diseases [5] , it will be of great interest in future research to examine the loss of Breg functionality and to verify the level of Breg activation and exhaustion during HIV infection.
We observed an increase in the frequencies of the CD24 hi CD27 + and PD-L1 + Breg subsets in HIV + treatment-naïve individuals. These subsets are related to a decrease of suppressive function and the ability to control the IL-10 production of B cells (Table 2) . PD-L1 hi -Breg are not the major IL-10 producer but might act through an alternative suppressive mechanism [10] . IL-10 and PD-L1 are induced during cellular activation [39] , and thus, the question arises of whether they are not produced by the same mechanisms of cellular activation or PD-L1 hi and IL-10 expression might be controlled by the same pathway. Since IL-10 is produced after cellular activation, one can hypothesize that CD24 hi CD27
+ Breg could negatively regulate the production of IL-10 from activated B cells in healthy individuals ( cells during inflammatory responses [52] , and BAFF does not promote IL-10 on CpG-activated B cells [53] . Because inflammation is pivotal in the HIV context, these last results could explain why we did not observe an increase in IL-10-producing B-cell frequencies in HIV + individuals. Thus, it will be very interesting to analyze if BAFF is implicated in the dysregulation of Breg and Treg compartments during HIV infection in further work. Therefore, further studies with larger sample sizes or patients could help to confirm these hypotheses. Indeed, the modest sample size is one of the limitations of our study, and the population studied was predominantly male (>75%), so generalization to females should also be done cautiously. Our study suggests that various Breg subsets could have different functions during B and T cell homeostasis during HIV-1 infection. Moreover, the dysregulation of Breg and Treg compartments was reverted in part by effective anti-retroviral therapy, and interrelation between these two groups of immunosuppressive cells was deeply perturbed during HIV infection. Therefore, Breg and Treg might be unable to respond adequately to HIV infection. Table. Cellular populations followed in this study. Description of the T and B-cell subsets followed in this study and the gating strategies.
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